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Shotgun‑metagenomics based 
prediction of antibiotic resistance 
and virulence determinants 
in Staphylococcus aureus 
from periprosthetic tissue on blood 
culture bottles
Adriana Maria Sanabria1*, Jessin Janice1,2, Erik Hjerde3, Gunnar Skov Simonsen1,4 & 
Anne‑Merethe Hanssen1*
Shotgun‑metagenomics may give valuable clinical information beyond the detection of potential 
pathogen(s). Identification of antimicrobial resistance (AMR), virulence genes and typing directly 
from clinical samples has been limited due to challenges arising from incomplete genome coverage. 
We assessed the performance of shotgun‑metagenomics on positive blood culture bottles (n = 19) 
with periprosthetic tissue for typing and prediction of AMR and virulence profiles in Staphylococcus 
aureus. We used different approaches to determine if sequence data from reads provides more 
information than from assembled contigs. Only 0.18% of total reads was derived from human DNA. 
Shotgun‑metagenomics results and conventional method results were consistent in detecting S. 
aureus in all samples. AMR and known periprosthetic joint infection virulence genes were predicted 
from S. aureus. Mean coverage depth, when predicting AMR genes was 209 ×. Resistance phenotypes 
could be explained by genes predicted in the sample in most of the cases. The choice of bioinformatic 
data analysis approach clearly influenced the results, i.e. read‑based analysis was more accurate for 
pathogen identification, while contigs seemed better for AMR profiling. Our study demonstrates high 
genome coverage and potential for typing and prediction of AMR and virulence profiles in S. aureus 
from shotgun‑metagenomics data.
Staphylococcus aureus is an important opportunistic pathogen considered as the most common cause of peripros-
thetic infections (PIs)1–5. The emergence and spread of resistance pose an increasing threat to public health, in 
particular, methicillin-resistant S. aureus (MRSA)6. The success of S. aureus as a pathogen is in part due to its 
ability to develop resistance to a wide variety of antimicrobial compounds. Additionally, S. aureus can adapt to 
a biofilm mode of growth whereby infections become persistent and recurrent, particularly in association with 
prosthetic  implants7.
Microbiological diagnosis of PJI is challenging. A variety of tools are available for facilitating the diagnosis 
of PJI, including emerging technologies such as metagenomic  approaches8. The use of shotgun-metagenomics 
(SMg) for the analysis of clinical specimens has emerged as a promising approach for pathogen identification, 
antimicrobial resistance (AMR) identification and outbreak investigation in clinical microbiology laboratories. 
This approach has been used for the analysis of different types of clinical specimens, including samples related 
to PJI, e.g. synovial  fluid9,10, sonication  fluid11–14 and  tissue15, mainly for the identification of pathogens.
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The advantage of using direct material in SMg is mainly short turnaround time for identification of patho-
gens, and the use of e.g. Nanopore sequencing is very promising for rapid identification of pathogens within 
4–24  h14,16,17. However, in these studies, extracted DNA is contaminated with a high concentration of human 
DNA while the bacterial DNA yield is very low, and thus, leading to a low number of bacterial reads. In a previ-
ous study, we showed that SMg performed directly on positive blood culture bottles (BCBs) inoculated with 
periprosthetic tissue (PT), is a convenient method to identify potential pathogens causing  PJI18. However, beyond 
the identification of pathogens, SMg provides unlimited access to other clinically relevant genomic features such 
as antibiotic resistance, virulence genes profiles and strain-level  typing19,20.
Currently, SMg is considered in its infancy for pathogen characterization, including inference of antibiotic 
 susceptibility21. Challenges arise due to the diversity of drug resistance mechanisms, multidrug resistance, and 
incomplete genome coverage, leading to insufficient sequence reads for detection of  ARGs22. However, there are 
some studies that show the potential of SMg for the detection of  ARGs23–25 by comparing the genotype against 
the phenotype, or generating AMR profiles from SMg assemblies and comparing them with whole genome 
sequences (WGS) from isolates. The use of SMg on samples from bone and joint infections has been used where 
they could predict antibiotic susceptibility in 94.1% (monomicrobial) and 76.5% (polymicrobial) of the  cases15. 
However, in these studies, the main obstacle has been a high background of genetic material mainly derived from 
the host, which generates very few bacterial reads. Similarly, when using SMg data for subtyping bacteria, one 
of the main challenges is missing loci. This problem arises when coverage is too low to guarantee the presence 
of a read containing a given sequence in the targeted  genome26.
We previously showed that SMg on BCBs with PT resulted in acceptable high number of bacterial reads, 
genome coverage and genome sequencing  depth18. Here, we wanted to assess the potential of SMg for the 
identification and typing of the most common cause of PJI, S. aureus, and the prediction of virulence and AMR 
directly from clinical samples.
Results
Sequencing data. SMg sequencing from the 19 samples resulted in a mean number of 3,990,292 reads per 
clinical sample (range 2,608,766–8,086,037). Sequencing of DNA from the sample spiked with S. aureus and 
the negative control produced 5,942,038 and 11,192,852 reads, respectively (Supplementary Table S1). Samples 
contained a lower proportion of reads classified either as human or horse or PhiX, while 98% of the reads did not 
map to any of the reference sequences used for the alignment (Supplementary Table S2 and Fig. S1).
After data preprocessing, a mean number of 3,700,731 reads remained for further taxonomical classification 
while from the negative control only 187,094 reads (1.67%) remained for taxonomical analyses (Supplementary 
Table S3). Kraken taxonomically classified a mean proportion of 98.36% reads, with 95.74% bacterial reads 
(Fig. 1 and Supplementary Table S4). Assembly with metaSPAdes yielded a mean number of 232 contigs (range 
134–378), with a mean total size of 3.1 Mb (range 2.6–4.8 Mb) in the clinical samples and 213 contigs for a 
total length of 2.7 Mb in the sample spiked with S. aureus (Supplementary Table S5). The total number of base 
pairs was higher in polymicrobial samples than in monomicrobial ones (4.8 Mb vs 2.7 Mb, respectively, t-test 
and P-value < 0.0001). The mean of the “maximum contig size” was 262,574 bp (median 264,931 bp, maximum 
425,306 bp) in the clinical samples and 218,856 bp in the spiked sample, and no significant difference was 
observed between polymicrobial and monomicrobial samples (184,461 bp and 283,495 bp, respectively, t-test and 
P-value = 0.149). Binning with MaxBin in polymicrobial samples grouped a mean number of 43 contigs in the 
bin assigned to S. aureus (range 39–51) with a mean total of 2.6 Mb (range 2.6–2.7 Mb) and a mean maximum 
length 297,040 bp (234,035–381,826 bp).
Identification of S. aureus by SMg. The taxonomical classification was performed using Kraken on 
reads and assembled contigs. When the taxonomical classification from the reads identified multiple highly 
abundant species (polymicrobial samples), contigs were grouped by species into bins, and then used for taxo-
Figure 1.  Proportion of reads taxonomically classified as human, horse, PhiX, microbial and unclassified.
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nomical classification. Relative abundance (determined by Bracken) from the most abundant species in the 
samples varied depending on the selected approach. The bin classified as S. aureus was used for downstream 
analyses for pathogen characterization.
Staphylococcus aureus was identified in all the samples by SMg. S. aureus (19/19) and S. agalactiae (4/19) 
was identified from both the reads and contigs. S. aureus was the most abundant species identified by SMg, 
with exception of samples 7 and 9, where S. agalactiae was more abundant (86.4% and 85.8%, from the reads, 
respectively) (Table 1 and Supplementary Fig. S1).
We identified some reads assigned to S. aureus (10.3%) in the negative control. The reads were evaluated by 
mapping them against a S. aureus reference genome (accession number GCF_000144955.1). Results showed that 
4% of the reads mapped to the reference genome and 6% of the reference genome was covered. When visualizing 
the mapping results, reads mapped with genetic areas belonging to coding sequences annotated as RNAs with a 
very low coverage depth, and they were not distributed all over the genomes. Also, other species were found in 
the NC but in a very low abundance except for the species Bacillus cereus (81.5%) which was the most abundant 
species found. (For further details on the taxa identified in the negative control, see Sanabria et al.27).
Staphylococcus aureus antibiotic resistance determinants by SMg. The presence of antibiotic 
resistance genes (ARGs) was determined by SMg from the reads and contigs for all the samples, and from the 
bins classified as S. aureus in polymicrobial samples (Sample 6, 7, 8 and 9). The presence of ARGs found in the 
reads, contigs and bins using the the NCBI bacterial antimicrobial resistance reference gene database as refer-
ence, were determined, and compared with the results obtained by the phenotypic antimicrobial susceptibility 
testing (AST) (Table 2, Supplementary Tables S6 and S7).
The mean coverage depth when predicting ARGs from the reads was 209x (Supplementary Table S6). We 
applied a threshold of a minimum 20 × coverage depth, 90% sequence identity and 90% sequence coverage for 
determining the presence of ARGs. In total, we were able to identify three different resistance genes in S. aureus 
(tet38, blaZ and fosB) in the 20 samples (including the spiked sample) by SMg. A higher number of ARGs were 
detected in the samples using the contigs approach compared with the reads approach (43 and 20 predictions 
in total, respectively).
Table 1.  Bacteria identified in the samples and in the positive control (PC) by MALDI-TOF from blood 
culture bottles (BCBs) and by Kraken from the shotgun-metagenomics (SMg) with their relative abundance 
(percentage in parentheses) determined by Bracken on the reads, contigs and bins.







1 1 S. aureus S. aureus (99.9%) S. aureus (100%)
2 2 S. aureus S. aureus (99.9%) S. aureus (100%)
3 3 S. aureus S. aureus (99.9%) S. aureus (100%)
4 4 S. aureus S. aureus (99.3%) S. aureus (98.6%)
5 5 S. aureus S. aureus (99.9%) S. aureus (100%)
6 6 S. aureus S. aureus (90.9%)S. agalactiae (8.5%)
S. aureus (60.6%)
S. agalactiae (39.4%)
1 S. aureus (100%)
2 S. agalactiae (100%)





1 S. agalactiae (97%)S. aureus (2%)
2 S. aureus (100%)
8 8 S. aureus S. aureus (97.6%)S. agalactiae (2.2%)
S. aureus (51.5%)
S. agalactiae (48.2%)
1 S. aureus (100%)
2 S. agalactiae (100%)
9 9 S. aureus S. agalactiae (85.8%)S. aureus (11.4%)
S. agalactiae (39.8%)
S. aureus (60.3%)
1 S. agalactiae (94.8%)
2 S. aureus (100%)
10 10 S. aureus S. aureus (99.8%) S. aureus (100%)
11 11 S. aureus S. aureus (98.2%) S. aureus (98.3%)
12 12 S. aureus S. aureus (99.8%) S. aureus (100%)
13 13 S. aureus S. aureus (99.4%) S. aureus (100%)
14 14 S. aureus S. aureus (99.6%) S. aureus (100%)
15 15 S. aureus S. aureus (99.4%) S. aureus (100%)
16 16 S. aureus S. aureus (99.9%) S. aureus (99.0%)
17 17 S. aureus S. aureus (89.8%) S. aureus (99.2%)
18 2 S. aureus S. aureus (89.7%) S. aureus (97.6%)
19 1 S. aureus S. aureus (99.9%) S. aureus (84.7%)
PC NA S. aureus S. aureus (99.9%) S. aureus (95.1%)
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:20848  | https://doi.org/10.1038/s41598-021-00383-7
www.nature.com/scientificreports/
The gene tet38 encoding the chromosomally encoded efflux pump of S. aureus was detected across all samples. 
The other genes detected, corresponded to the blaZ gene (35%), and the fosfomycin resistance gene fosB (50%). 
In the polymicrobial samples, the gene tetM was also detected, but it was not identified in the S. aureus bins.
Resistant phenotypes were observed only for penicillin in 12/19 samples (63.5%), and for fusidic acid in 2/19 
(10.5%) samples (Table 2). The penicillin resistant phenotype could be explained by the presence of the blaZ gene 
in most of the samples. However, in samples 6, 7 and 9, the penicillin resistance phenotype could not be explained 
by the genotypic profile generated from the reads, contigs or bin. The fusidic acid resistance phenotype could 
not be explained by the results obtained genotypically. Chromosomal point mutations in the genes reported to 
induce resistance to fusidic acid (genes fusA and fusE) were not identified. Contrariwise, mutations in the grlA 
gene were observed in six samples (31.6%). Although, no ciprofloxacin resistance phenotype was observed in 
any of them (Table 2).
Virulence factors. Overall, a total of 73 genes coding for virulence factors (VFs) were found by SMg in S. 
aureus (Supplementary Table S8) and a mean of 55 virulence genes (range, 50–62) were detected per sample 
using the VFDB and thresholds of 90% identity and 90% sequence coverage. Toxins, adhesins and immune 
evasion molecules were among the genes predicted. Genes encoding 40 virulence factors were present in all the 
samples, e.g., the cap8 capsule genes (cap8A-G and cap8L-P), iron sequestration operon isdA-isdG, and exotox-
ins hla, hld, hlgA-C, among others. Additionally, in five samples the toxic shock syndrome toxin 1 (tsst-1) gene 
was detected.
Virulence genes recognized as belonging to S. agalactiae were removed from the analysis of polymicrobial 
samples. Several virulence genes known or proposed to play a role for the pathogenicity of S. aureus in PJI were 
identified from the metagenomes (Fig. 2 and Table 3). Prokka annotation tool was used to confirm the virulence 
genes presence or absence in the metagenomes. Figure 2 and Table 3 represent the Prokka results on the selected 
virulence genes found associated with PJI together with the results obtained when using the VFDB applying the 
thresholds (90% identity and 90% sequence coverage).
MLST and cgMLST analysis. The S. aureus Multilocus sequence types (ST) were identified for all the 
samples at both core genome and whole genome (core genome + accessory genome genes) level (Fig.  3 and 
Supplementary Table S9). Typing from SMg data showed that S. aureus in our samples is of different lineages. S. 
aureus in the samples represent six different clonal complexes (CCs), and they belonged to different STs (ST45 
(30%), ST121 (15%), ST30 (15%), ST22 (10%), ST5 (10%), ST15 (5%), ST243 (5%), ST7 (5%) and ST97 (5%)). 
Table 2.  Antibiotic resistance genes (ARGs) detected in this study using different approaches (reads, contigs 
and bins) with the NCBI bacterial antimicrobial resistance reference gene database, chromosomal mutations 
detected using ResFinder, and antibiotic resistance phenotype observed by the conventional antibiotic 
susceptibility testing (AST).
Sample no. Conventional antibiotic susceptibility test Chromosomal mutations
ARGs detected from shotgun-
metagenomics
Reads Contigs Bins
1 Penicillin blaZ, tet38 fosB, blaZ, tet38
2 Penicillin blaZ, tet38 blaZ, tet38
3 grlA tet38 tet38
4 Penicillin fosB, blaZ, tet38
5 grlA tet38 tet38
6 Penicillin grlA tet38 tet38
7 Penicillin tetM, tet38 fosB, tetM, tet38 fosB, tet38
8 tet38, tetM tet38
9 Penicillin tet38, tetM fosB, tetM, tet38 fosB, tet38
10 grlA tet38
11 fosB, tet38, blaZ
12 PenicillinFusidic acid fosB, blaZ, tet38
13 blaZ, tet38
14 Penicillin blaZ fosB, blaZ, tet38
15 Penicillin grlA blaZ, tet38 blaZ, tet38
16 PenicillinFusidic acid blaZ, tet38 fosB, blaZ, tet38
17 tet38
18 PenicillinFusidic acid grlA blaZ, tet38
19 PenicillinFusidic acid blaZ, tet38 fosB, blaZ, tet38
PC tet38 fosB, tet38
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With respect to polymicrobial samples 7 and 9, typing analyses from both the contigs and the bins classified S. 
aureus as belonging to the same sequence type (ST5). CCs could not be identified for six samples (23%). Samples 
belonging to the same patient (sample 1 and 18; sample 2 and 19) did not cluster together and did not belong 
to the same ST (Fig. 3 and Supplementary Table S9). The S. aureus isolates analyzed here represent eight phy-
logenetically diverse STs. cgMLST subdivided the samples into 13 different complex types (CT, 21,308–21,321) 
(Supplementary Table S9).
Figure 2.  Virulence genes predicted by SMg from S. aureus in PT samples in this study. 
Table 3.  Prevalence of virulence genes known or proposed to play a role in S. aureus pathogenicity in PJI 
predicted from SMg in this study using 90% identity and 90% sequence coverage.
Virulence gene Product
Approach
Prokka annotation VFDB annotation
aur Zinc metalloproteinase aureolysin 100 50
clfA Clumping factor A fibrinogen-binding protein 35 25
cna Collagen adhesin precursor 70 10
fnbA Fibronectin-binding protein A 100 25
hld Delta-hemolysin 100 100
hlgA Gamma-hemolysin chain II precursor 100 100
hlgB Beta-hemolysin 100 100
hlgC Gamma-hemolysin component C 100 100
sdrD Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein 65 25
sdrE Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein 75 25
spa Immunoglobulin G binding protein A precursor 100 60
sspA Serine protease; V8 protease; glutamyl endopeptidase 100 100
sspB Staphopain cysteine proteinase SspB 100 100
sspC Staphostatin B 100 100
hly/hla Alpha-hemolysin precursor 100 100
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Discussion
Here, we assessed the performance of SMg for the prediction of ARGs, virulence gene determinants and typing 
of S. aureus from clinical PT samples on BCBs. We investigated if there was a difference in outcome from ana-
lyzing sequencing data from reads and contigs, and our data analysis followed different analytical approaches in 
order to identify the procedures that may give the most relevant and accurate information from our SMg data.
It is established that it is possible to analyze sequence data without assembly, but most analyses can be 
improved by constructing longer contiguous sequences (contigs) through assembly  processes28. According to 
our results, the selection of approach to some degree depends on what type of information you require from the 
data. For instance, if the aim is pathogen identification, taxonomy from the reads is sufficient while if AMR is 
the focus, the contigs approach will provide a more comprehensive resistome resolution.
For identification of potential pathogen(s) causing PJI, we found that the relative abundance of the taxa 
was influenced by the approach used to analyze the data. This was evidenced by the differences in abundance 
obtained, especially in the polymicrobial samples. We observed that the proportion of contigs classified into a 
certain taxonomical level is also influenced by the genome size. Determining the taxa present and the relative 
level or number of cells of one taxon vs another (e.g., polymicrobial samples) in a clinical sample is important 
for identifying the pathogen(s) causing the infection. Our results suggest that analyzing reads provides a more 
trustworthy representation of the species in a clinical sample than analyzing contigs. Moreover, it is considered 
that the reads will describe more accurately the proper distribution of species in the sample and provide a more 
accurate and specific assignment of taxa than using the  contigs29. This statement applies especially to quantitative 
community profiling and identification of organisms with close relatives in the database as in the case of clinical 
microbiology, where the focus is mainly the presence or absence of infectious pathogens, which are well studied 
and have many completed genomes in the reference  databases30. In addition, it could also be errors in joining 
contigs from two closely related species. Specificity is lost when working with contigs as the quality of the assem-
bly will depend strongly on the length and quality of the reads, sometimes misrepresenting the original  sample29.
Interpretation of SMg results can be challenging, especially when distinguishing microorganisms actually 
present in the sample from  contaminants31. In this study, S. agalactiae was detected in four samples by SMg, but 
Figure 3.  Minimun-spanning tree based on cgMLST (a) and wgMLST (b) allelic profiles of S. aureus genomes 
obtained from SMg. Color nodes according to sequence type. The number in the connecting lines illustrates the 
number of targeted genes with differing alleles.
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it was only detected in one of these samples by the laboratory method (BCBs). S. agalactiae has been reported 
as one of the most common pathogens found together with S. aureus in polymicrobial  PJIs32. This could suggest 
an increased sensitivity of SMg to detect bacteria, or alternatively a contamination problem in the laboratory 
workflow. These findings highlight the importance of the use of parallel negative controls (no-template control) 
and DNA spiked positive controls to exclude or identify sources of contamination and minimize false-positive 
 results33. Bioinformatic tools have been developed to streamline identification of contaminants and/or cross-
contamination, like e.g.  Recentrifuge34 and  Decontam35.
S. aureus has been studied extensively with a special focus on resistance and virulence. In this study, only 
resistance to penicillin (63.5%) and fusidic acid (10.5%) were observed by AST. No MRSA isolates were detected, 
neither by phenotypical nor genotypical testing. This result is not surprising, since Norway has a very low 
prevalence of  MRSA36.
Although SMg is a promising approach, the in silico translation from genotype into phenotype relies on 
the knowledge about the genomic resistance  determinants37. Our SMg analysis allowed the prediction of the 
genotypical resistance profile from S. aureus present in the samples. The ARG tet38 was detected in all samples. 
However, tetracycline resistant phenotypes were not observed, and the presence of tet38 is not enough to produce 
a resistant phenotype. The tet38 determinant is an inherent, chromosomally encoded efflux pump in S. aureus 
and resistance to tetracyclines is often associated with plasmid-mediated genes encoding active efflux pumps or 
proteins that protect ribosomes from drug  action38.
In three of the metagenomic samples with phenotypic penicillin resistance, the blaZ gene was absent (25%). 
Similarly, fusidic acid resistance phenotype was observed in two samples (sample 12 and 16). The presence of the 
fusB gene or mutations in fusA (encoding EF-G) or fusE (encoding ribosome protein L6) genes known to cause 
fusidic acid resistance were not detected in the metagenomes. Therefore, the phenotype could not be explained 
by the results obtained genotypically. Overall, interpretation of cases where phenotyping reports resistance but 
WGS methods predict susceptibility is considered  difficult39.
Sometimes, detection of ARGs may be challenging due to the variable location of the resistance genes, since 
some of them can be on a plasmid or integrated into the chromosome, as is the case of the blaZ gene and the 
fusB gene which has been found on S. aureus plasmid or on phage-related resistance islands integrated into 
the  chromosome40. Bacterial isolates with plasmid-encoded copies may have very high (if multiple copies are 
carried) or very low (because of poor mapping to the reference) coverage in that  region41,42. As a result, these 
regions may be rejected as low coverage when predicted from the reads, or as poor quality by the assembly tools 
when predicted from the contigs and bins since they fall outside the coverage level of the rest of the genome. 
This problem may be overcome in the future with long-read sequencing methods such as nanopore sequencing 
or alternative methods for de novo assembly.
Another possibility is the presence of small colony variants (SCV) being present phenotypically but overgrown 
in WGS culture and thus not represented in the  sequence39. This phenomenon has been observed for resistance 
associated with fusidic  acid43.
We observed that three of the five samples with phenotype-genotype disagreement for penicillin resistance 
were found to be polymicrobial by SMg (samples 6, 7 and 9). In samples 7 and 9, S. aureus was not the most abun-
dant species present in the sample (< 12%) which may affect the prediction of ARGs by a lower sequence coverage.
Prediction of ARGs was done at the reads, contigs and bin level. The total number of different genes detected 
(3 ARGs) was influenced by the parameters selected to report a gene as present, as these parameters constitute 
a trade-off between specificity and  depth44. We used strict parameters, and only ARGs that had ≥ 90% similarity 
and ≥ 90% sequence coverage to that of the reference were reported from the reads, contigs and bins. In addition, 
at the read level, only ARGs with at least 20 × coverage depth were considered as present. The selection of ARGs 
using stringent cutoffs (≥ 90% per read or contig) can increase the probability of targeting genes that are actually 
 functional44. However, thresholds should be adapted for certain genes (e.g., blaZ, which can be chromosomally 
integrated or carried on plasmids)39.We consider that the high coverage depth (> 200 ×) is an advantage in our 
SMg approach.
Most of the tools developed for identifying ARGs from metagenomic reads can detect acquired ARGs, but are 
not able to identify point mutations associated with  AMR45. The focus here was on acquired resistance since we 
have used the tools Groot or ABRicate with the NCBI bacterial antimicrobial resistance reference gene database. 
However, ResFinder was used to detect chromosomal point mutations associated with antimicrobial resistance 
from the contigs. In our study, more genes were detected at the contig level than at the read level. The detection of 
more ARGs from the contig-based approach may be explained by the fact that it is easier to reach a high sequence 
coverage of the gene (90%) from contigs (which are longer) than by reads that are shorter in length. We consider 
that prediction of ARGs at the contig level is the best approach when looking for ARGs. However, it is important 
to highlight that both approaches are valid for certain purposes, and both have their limitations. Read-based 
prediction of ARGs provides an advantage when dealing with metagenomic samples, as ARGs in less abundant 
organisms can be predicted despite low coverage, which may be missed by assembly-based methods owing to 
incomplete or poor  assemblies46. Detecting ARGs from reads is more prone to false positive results because of 
sequencing errors present in single reads or from DNA contamination from other bacteria. A previous study 
comparing ARG detection from reads and contigs suggested using both approaches when the sequence cover-
age is set to a high percentage, since it is possible that ARGs may be separated into different contigs when the 
number of reads is too low during the assembly  process23. The use of long-read sequencing can overcome this 
problem as shown in other  studies17,47–49. However, there are some limitations for achieving enough bacterial 
reads to ensure high accuracy when predicting ARGs.
Strategies for predicting AMR phenotypes in polymicrobial samples present an interesting  challenge50. We 
tested the binning approach for the prediction of ARGs in S. aureus and we found that it gives similar results 
as prediction of ARGs in monomicrobial samples for most of the genes with exception of the blaZ gene. This 
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approach allowed us to separate the contigs belonging to S. agalactiae from the contigs belonging to S. aureus 
and predict the S. aureus resistance profile, even though there were not many contigs (mean, 44, 3 contigs; range 
39–51). This means that AMR genotype predictions could be made from contigs that are binned in a metagen-
omic assembly, even when they belong to a species that is not in a high abundance. In this study, the binning 
strategy was no further evaluated. Conclusions from bins should be made with precaution since the binning 
process can lead to incorrect assumptions due to misbinning (the wrong assignment of a genome fragment from 
one organism to another), namely if the abundance of the species is very similar, which may lead to neglection 
of specific  determinants51.
Apart from antibiotic resistance, virulence of a pathogen is also an important factor clinicians may be con-
cerned about when considering appropriate treatment. Horizontally acquired virulence genes can directly con-
tribute to an infection outbreak, and thus, early identification of virulence factors is  important49,52. In our study, 
we identified some VFs that are known or proposed to play a role in S. aureus PJI, e.g. genes involved in coloni-
zation and attachment of host tissue or implanted biomaterials such as the adhesins clfA and fnbA that encode 
the fibrinogen and fibronectin-binding proteins,  respectively53. We have observed that the database used, and 
the thresholds established to consider the presence of a VF play an important role in the results. The need for a 
continuously updated curated database is a key challenge for SMg sequencing methods. Thresholds should be 
adapted for certain genes to improve the prediction and for quality  control39. Specific VFs may also require the 
use of different approaches to confirm the results, e.g. to detect genes that are highly polymorphic as the spa gene.
MLST was used for strain level typing including a contig-based approach, which means that we had sufficient 
depth for assembly from the metagenome. wgMLST demonstrated that S. aureus in the samples consisted of 
several lineages. Our MLST results were in accordance with results from the population-based Tromsø Staph 
and Skin Study, showing that CC30, CC45 and CC15 were the most common CCs in  MSSA54. Additionally, the 
most common S. aureus lineages in PJI reported in a recent study, were CC30, CC45, CC5, CC15 and CC22. S. 
aureus in our study belonged to the same  CCs32,54.
Our study has several limitations. First, the sample size was small (n = 19), and we only analyzed a limited 
number of polymicrobial samples. Second, S. aureus isolates were not whole genome sequenced for comparison 
and confirmation of ARG and VF profiles. Third, no clinical data about the patients were obtained making it 
difficult to classify the samples as true PJI. Fourth, we have used short-read sequencing which makes detec-
tion of ARGs on mobile genetic elements difficult. Long-read sequencing may overcome this limitation. Fifth, 
we only predicted acquired resistance, which made it difficult explaining the disagreement found between the 
phenotype and the genotype for penicillin resistance. Errors in sensitivity and specificity of ARG prediction can 
have different consequences for PJI treatment. False negatives (phenotypically resistant and SMg-susceptible) can 
lead to inadequate treatment of a resistant infection, increasing morbidity and mortality, whereas false positives 
(phenotypically susceptible and SMg-resistant) may lead to inappropriate antibiotic use and increase the risk of 
resistance  development55. Sixth, we did not include blank negative controls to help identifying genuine sources 
of contamination coming from the environment or from the reagents. We did not calculate the turnaround time 
since it was not the focus of the study. However, other studies have estimated the time for SMg using the Illumina 
technology estimating the total time to 29 h (24–94) from sample extraction to identification and AMR  profile56. 
Our protocol would probably also fall into similar turnaround time from BCB positivity to pathogen ID.
Our approach is primarily useful for those using SMg on specimens related to PJI cultured on BCBs, such as 
synovial fluid, sonication fluid and periprosthetic tissue. It can also be useful for further validation and stand-
ardization for the general use of BCBs inoculated with clinical sample. Today, the high costs of our SMg method 
cannot justify for application on a routine  basis56. However, in this study, we obtained a high enough sequencing 
depth, making it possible to multiplex samples and thereby reducing costs considerably.
We do not believe that SMg can replace conventional culturing, but it can be a potential diagnostic tool to 
support conventional culture in cases when PJI diagnosis is challenging, e.g. fastidious/slow-growing micro-
organisms, polymicrobial infections, discrepancies between conventional methods, when culture-negative but 
with clinical sign of  infection57, and in complicated infections with antibiotic resistant bacteria and long-term 
antibiotic  treatment58. In practice, there are no real problems in identifying microorganisms from BCBs. The 
added value of SMg over classical blood culturing, is mainly that SMg, in addition to pathogen identification, 
allows extra information in one single procedure, e.g. detecting coinfections, predicting AMR, detecting virulence 
factors, and bacterial typing. It is still a long way until SMg can be used in the clinical microbiology laboratory. 
Our SMg approach, including enrichment of microbes using BCBs and human DNA depletion method, has been 
successful, enabling AMR-prediction, virulence gene detection and bacterial typing.
In conclusion, this study showed that SMg from BCBs inoculated with PT, allowed the identification of 
potential PJI pathogens and strain-level typing of S. aureus. We obtained S. aureus ARGs and virulence gene 
profiles from both monomicrobial and polymicrobial samples. However, the use of this approach for the detec-
tion of AMR to help guide clinical treatment needs to be further elucidated, due to the disagreement between the 
AMR phenotype and genotype. We conclude that the approach chosen for analyzing SMg data (reads, contigs or 
metagenomic assembled genomes) will have a key impact on the results. Precise AMR prediction is required for 
mainstream adoption of SMg into the clinical microbiology laboratory. Thus, several improvements are needed 
for AMR prediction using SMg, including a better understanding of the mechanisms underlying AMR and the 
procedures (including workflows, tools and databases) that may give the most relevant and accurate information 
when analyzing SMg data.
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Methods
Ethics statement. This study was performed in accordance with the ethical guidelines established by UiT—
The Arctic University of Norway. The project has been evaluated by the Regional Committee for Medical and 
Health Research Ethics, REC North, Norway (document no. 2016/1247/REK nord), concluding that ethical 
approval was not required. According to the Norwegian guidelines, informed consent of the patients is not 
needed and there were not ethical issues to consider due to the use of anonymous clinical samples and the devel-
opment of methodological procedures.
Sample collection. Periprosthetic tissue samples (from hip, knee, elbow, ankle, and shoulder) routinely 
submitted to the Department of Microbiology and Infection Control at the University Hospital of North Norway 
(UNN), Tromsø, Norway, were included in this study. Nineteen positive BCBs inoculated with PT from 17 indi-
vidual patients with suspicion of PJI were used in this study. Clinical samples were selected on the basis of being 
positive for S. aureus by the BCB  method18, either monomicrobial (n = 18) or polymicrobial (n = 1). Samples 
were collected continuously over a 28-month period (August 2017–December 2019). Samples were anonymized 
and de-identified. All samples were taken from aerobic bottles (Bact/Alert® FA plus bottles, bioMérieux, Marcy 
l’Etoile, France).
Five of the 19 clinical samples in this study, in addition to one positive control (spiked sample, BCB inoculated 
with tissue spiked with S. aureus ATCC 2592) and one negative control (DNA not subjected to human DNA 
depletion, extracted from a BCB enriched with horse blood and inoculated with sterilized tissue from a donor 
with no suspicion of infection) were obtained from a sample collection in a previous  study18,27. No blank nega-
tive control was included. For further details on the BCB sample preparation method and on the controls, see 
Sanabria et al.27. Bacterial identification was performed using matrix-assisted laser desorption ionization-time 
of flight mass spectrometry (MALDI-TOF® MS Bruker Daltonics—microflex™). An overview of all the samples 
included in this study, is shown in Table 1.
Antibiotic susceptibility testing. Antibiotic susceptibility testing (AST) of S. aureus isolates was per-
formed by disc diffusion test according to EUCAST guidelines and the breakpoint table v.10.0 (2020)59. The 
antibiotics tested were penicillin (10 µg), trimethoprim-sulfamethoxazole (25 µg), cefoxitin (30 µg), fusidic acid 
(10 µg), clindamycin (2 µg), erythromycin (15 µg), linezolid (10 µg), tetracycline (30 µg), norfloxacin (10 µg), 
ciprofloxacin (5 µg), gentamicin (10 µg) and rifampicin (5 µg) (Oxoid, Basingstoke, UK).
DNA preparation. DNA was extracted and processed as previously  described18. In short, all samples were 
pre-treated using MolYsis™ Basic5 kit (Molzym, Bremen, Germany) to deplete human and horse DNA before 
DNA extraction using the QIAamp BiOstic Bacteremia DNA Kit (Qiagen, Hilden, Germany). Total DNA con-
centration was measured using a Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA, USA) and DNA 
quality was determined by Nanodrop.
Metagenomic sequencing. Sequencing libraries were prepared as previously  described18, using the 
ThruPLEX® DNA-seq Kit (Rubicon Genomics, USA) following the manufacturer’s instructions. Approximately 
100 ng of DNA was used as input for library preparation from the clinical and spiked samples. The sequencing 
process was performed at the Norwegian Sequencing Centre, Oslo, using a MiSeq sequencer (Illumina Inc., San 
Diego, CA, USA) with v2 chemistry and 500 cycles for 250 bp paired-end sequencing. Samples were multiplexed 
with four samples per lane.
Bioinformatic data analysis. Our SMg bioinformatics pipeline was created and optimized, based on pub-
licly available tools and pipelines and tools from other SMg  studies9,11–13,15,23,60,61. The bioinformatic analysis 
followed in this study is summarized in Fig. 4. The quality of the raw reads in fastq format was assessed using 
FastQC software v0.11.8 (http:// www. bioin forma tics. babra ham. ac. uk/ proje cts/ fastqc/). Optical duplicates were 
removed using the program Clumpify v38.36 from BBTools suite (https:// jgi. doe. gov/ data- and- tools/ bbtoo ls/) 
with default parameters. Adapter sequences were trimmed off and the poor-quality reads were removed using 
BBDuk of BBTools suite. The minimal read length and Phred score were set to 50 nucleotides and 20, respec-
tively. In order to filter out known sources of contaminant host DNA, the reads mapped against the reference 
genomes of human GRCh38.p13 (GCF_000001405.39), horse (GCF_002863925.1) and the PhiX phage (Escher-
ichia virus phiX174, GCF_000819615.1) aligning with Bowtie2 in the tool FastQ Screen v0.13.062. Unmapped 
reads were used in subsequent analyses.
Data analyses in this study followed different approaches: using the preprocessed reads directly and using 
assembled contigs or bins for monomicrobial and polymicrobial samples, respectively. Reads were assembled 
into contigs using  metaSPAdes63 from SPAdes v.3.14.064 and the quality of the assemblies was assessed using 
QUAST v5.0.265. Resultant contigs were annotated using Prokka v.1.13 (http:// github. com/ tseem ann/ prokka). 
Contigs can be grouped by species into discrete units, referred to as bins, which were predicted using the tool 
MaxBin v.2.2.766, for recovering the S. aureus genome from the metagenomic datasets in polymicrobial samples.
Species identification on reads, contigs and bins was performed using Kraken v1.1.167 (as illustrated in 
Fig. 4) and the 8 GB DustMasked MiniKraken database (as of Oct. 18, 2017) with default parameters. Species 
relative abundance was determined using  Bracken68. The detection of antimicrobial resistance genes (ARGs) 
from the reads was determined using the tool Groot v.1.0.269 (https:// github. com/ will- rowe/ groot). ARGs and 
virulence genes from the assembled contigs and bins were detected using ABRicate v0.8 (https:// github. com/ 
tseem ann/ abric ate). For the detection of ARGs with Groot and ABRicate the NCBI bacterial antimicrobial 
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resistance reference gene database (BioProject accession number PRJNA313047, as of April  24th, 2020) was used. 
Moreover, chromosomal point mutations associated with antimicrobial resistance were identified with ResFinder 
v.4.1 (Point Finder database as of Feb. 1, 2021). For detection of virulence genes, the virulence factor database 
(VFDB) was  used70. The thresholds used for determining the presence of ARG genes and VFs were set as 90% 
identity and 90% sequence coverage. Additionally, for ARGs prediction from the reads, a coverage depth of at 
least 20 × was considered to report an ARG as present. Presence or absence of several VFs in the metagenomes, 
known or proposed to play a role in S. aureus pathogenicity in PJI were confirmed using the results from Prokka 
v.1.13. We used default parameters for all the bioinformatic tools unless it is stated.
Typing. The assembled contigs and the bins were imported into SeqSphere + software v.6.0.2 (Ridom GmbH, 
Münster, Germany) for a gene-by-gene allele calling comparison using the S. aureus species-specific scheme 
within SeqSphere + for a cgMLST scheme for comparison of the 1,816 core loci in S. aureus, and an accessory 
typing scheme (wgMLST) with 706 accessory loci. Loci that flagged as failed (i.e., found but bearing frameshifts, 
or a differing consensus sequence, or having too-low coverage) were considered absent. Phylogenetic trees were 
constructed in SeqSphere + using a minimum-spaning tree; missing values were pairwise ignored. The cluster-
alert distance was set at a default of 24 allelic  differences32.
Statistical analysis. Descriptive statistics for categorical variables were based on percentages and frequen-
cies and was used to determine the prevalence of the ARGs and VFs, while continuous variables were based 
on means, medians, and interquartile ranges (IQRs) and was used to describe the results obtained from the 
sequencing data. In addition, t-test was used to evaluate if the differences between the total number of base pairs 
in polymicrobial and monomicrobial samples were statistically significant. The differences were considered sta-
tistically significant with p values < 0.0001. Data were analyzed utilizing GraphPad Prism software, version 8.3.0 
(GraphPad Software Inc., CA, US).
Data availability
The preprocessed reads generated for this study for each sample can be found in the European Nucleotide Archive 
(ENA) repository (www. ebi. ac. uk/ ena) under the project number PRJEB43858.
Figure 4.  Workflow summarizing the bioinformatic analyses in this study, including (a) data preprocessing, 
(b) data analyses approaches and (c) data analyses and interpretation. ARG antimicrobial resistance gene, VF 
virulence factor, AMR antimicrobial resistance.
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